TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pharmacorp Rx Inc. ( (TSE:PCRX) ) has shared an update.
PharmaCorp Rx Inc. has restated and refiled its Q2 2025 financial statements following an audit review, making accounting adjustments that do not affect its financial position. The changes include adjustments to intangible assets and working capital, with minimal impact on total assets and net cash. The company continues its strategy of acquiring pharmacies, enhancing its market presence in Canada.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. operates seven PharmaChoice Canada bannered pharmacies and is focused on acquiring more PharmaChoice Canada branded pharmacies as well as independently owned non-PharmaChoice Canada bannered pharmacies in Canada. The company aims to operate these under the PharmaChoice Canada banner, leveraging a strategic alliance with PharmaChoice Canada. PharmaCorp is listed on the TSX Venture Exchange under the symbol PCRX.
Average Trading Volume: 34,971
Technical Sentiment Signal: Buy
Current Market Cap: C$55.27M
Learn more about PCRX stock on TipRanks’ Stock Analysis page.